ERBB2 and breast cancer: To validate the microarray findings, we conducted qRT-PCR analysis of 17 mRNAs across five distinct breast cancer subtypes: Luminal A, Luminal B HER2-, Luminal B ER2+, Non-luminal HER2+, and TNBC.